The healthcare industry is witnessing significant growth in blood therapies, with plasmapheresis becoming an essential treatment for patients suffering from autoimmune diseases and blood disorders. This procedure involves removing harmful antibodies or proteins from the blood, offering effective treatment for conditions such as lupus, rheumatoid arthritis, multiple sclerosis, hemophilia, thrombocytopenia, and sickle cell anemia. Rising awareness of plasma donation, coupled with increasing prevalence of these disorders, is driving demand for advanced plasmapheresis machines across hospitals, clinics, blood donation centers, and ambulatory surgical facilities worldwide. The Plasmapheresis Machines Market is anticipated to expand at a CAGR of 8.2% from 2026 to 2034. Ongoing technological innovation, portable devices, and AI integration are transforming procedural efficiency and patient safety, enabling healthcare providers to adopt these advanced solutions ...